Dr. Atlal Abusanad discusses how biases in valuing capability and potential in female oncologists has led to their underrepresentation in prominent roles.
ASCO’s delegation to the American Medical Association (AMA) recently met virtually with the AMA’s House of Delegates (HOD), with a focus on payment reform models.
Despite the virtual nature of the AMA House of Delegates meeting, the decisions made there have a very real impact on our profession and the patients we serve.
My colleague and friend Ginny Mason and I discuss advocacy, "beating the odds," and her perspective 26 years out from an initial diagnosis of inflammatory breast cancer.
Although our societal meetings, including the AMA House of Delegates meeting, are shortened, they have never been more important than they are at this moment.
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by...
We must commit the same energy and focus we pour into conquering cancer to addressing systemic issues that affect the health of people of color in our country.
Dr. Ray Page and I discuss the important role that drug repository programs can play in helping our patients afford their treatment while reducing the financial toll on the cancer care delivery system.
At a time when every physician is needed, U.S. visa restrictions on international medical graduates are making it impossible for them to do the most good, writes Dr. Sreekanth Donepudi.